The expression of IGFs and IGF binding proteins in human carotid atherosclerosis, and the possible role of IGF binding protein-1 in the regulation of smooth muscle cell proliferation

Atherosclerosis

Volumn 220, Issue 1, 2012, Pages 102-109

  Wang, Jing ^a   Razuvaev, Anton ^a   Folkersen, Lasse ^a   Hedin, Erika ^a   Roy, Joy ^a   Brismar, Kerstin ^a   Hedin, Ulf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Carotid plaque; ERK1 2; IGF; IGFBP 1; SMC

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAROTID ATHEROSCLEROSIS; CELL ACTIVATION; CELL PROLIFERATION; CELL STIMULATION; CELLULAR DISTRIBUTION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; ILIAC ARTERY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CAROTID ARTERY DISEASES; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGES; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RNA, MESSENGER; SOMATOMEDINS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84155172981     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.10.032     Document Type: Article

References (30)

1. Clemmons D.R. Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat Rev Drug Discov 2007, 6:821-833.
2. Delafontaine P., Song Y.H., Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 2004, 24:435-444.
3. Shai S.Y., Sukhanov S., Higashi Y., et al. Smooth muscle cell-specific insulin-like growth factor-1 overexpression in APOE-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability. Arterioscler Thromb Vasc Biol 2010, 30:1916-1924.
4. Li Z.Y., Howarth S.P., Tang T., Gillard J.H. How critical is fibrous cap thickness to carotid plaque stability? A flow-plaque interaction model. Stroke 2006, 37:1195-1199.
5. Jia G., Cheng G., Soundararajan K., Agrawal D.K. Insulin-like growth factor-I receptors in atherosclerotic plaques of symptomatic and asymptomatic patients with carotid stenosis: effect of IL-12 and IFN-gamma. Am J Physiol Heart Circ Physiol 2007, 292:H1051-H1057.
6. Firth S.M., Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002, 23:824-854.
7. Gustafsson T., Andersson P., Arnqvist H.J. Different inhibitory actions of IGFBP-1, -2 and -4 on IGF-I effects in vascular smooth muscle cells. J Endocrinol 1999, 161:245-253.
8. Yu J., Iwashita M., Kudo Y., Takeda Y. Phosphorylated insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) inhibits while non-phosphorylated IGFBP-1 stimulates IGF-I-induced amino acid uptake by cultured trophoblast cells. Growth Horm IGF Res 1998, 8:65-70.
9. Jones J.I., Gockerman A., Busby W.H., Wright G., Clemmons D.R. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its arg-gly-asp sequence. Proc Natl Acad Sci USA 1993, 90:10553-10557.
10. Grant M.B., Wargovich T.J., Ellis E.A., et al. Expression of IGF-I, IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and -5 in human atherectomy specimens. Regul Pept 1996, 67:137-144.
11. Boes M., Booth B.A., Dake B.L., Moser D.R., Bar R.S. Insulin-like growth factor binding protein production by bovine and human vascular smooth muscle cells: production of insulin-like growth factor binding protein-6 by human smooth muscle. Endocrinology 1996, 137:5357-5363.
12. Panek B., Gacko M., Palka J. Metalloproteinases, insulin-like growth factor-I and its binding proteins in aortic aneurysm. Int J Exp Pathol 2004, 85:159-164.
13. Boquist S., Ruotolo G., Skoglund-Andersson C., et al. Correlation of serum IGF-I and IGFBP-1 and -3 to cardiovascular risk indicators and early carotid atherosclerosis in healthy middle-aged men. Clin Endocrinol (Oxf) 2008, 68:51-58.
14. Ezzat V.A., Duncan E.R., Wheatcroft S.B., Kearney M.T. The role of IGF-I and its binding proteins in the development of type 2 diabetes and cardiovascular disease. Diabetes Obes Metab 2008, 10:198-211.
15. Juul A., Scheike T., Davidsen M., Gyllenborg J., Jorgensen T. Low serum insulin-like growth factor i is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002, 106:939-944.
16. Hedin U., Thyberg J., Roy J., Dumitrescu A., Tran P.K. Role of tyrosine kinases in extracellular matrix-mediated modulation of arterial smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 1997, 17:1977-1984.
17. Ferrari F., Bortoluzzi S., Coppe A., et al. Novel definition files for human genechips based on geneannot. BMC Bioinformatics 2007, 8:446.
18. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta c(t)) method. Methods 2001, 25:402-408.
19. Vandesompele J., De Preter K., Pattyn F., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3. RESEARCH0034.
20. Hewish M., Chau I., Cunningham D. Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine. Recent Pat Anticancer Drug Discov 2009, 4:54-72.
21. Pryshchep O., Ma-Krupa W., Younge B.R., Goronzy J.J., Weyand C.M. Vessel-specific toll-like receptor profiles in human medium and large arteries. Circulation 2008, 118:1276-1284.
22. Miedema M.D., Conover C.A., MacDonald H., et al. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy. Am J Cardiol 2008, 101:35-39.
23. Harrington S.C., Simari R.D., Conover C.A. Genetic deletion of pregnancy-associated plasma protein-a is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Circ Res 2007, 100:1696-1702.
24. Andersson P., Gustafsson T., Arnqvist H.J. Insulin-like growth factor binding proteins-2 to -6 are expressed by human vascular smooth muscle cells. J Endocrinol 1999, 163:281-288.
25. Elgin R.G., Busby W.H., Clemmons D.R. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 1987, 84:3254-3258.
26. Motani A., Rutherford C., Anggard E.E., Ferns G.A. Insulin-like growth factor binding protein-1 inhibits arterial smooth muscle cell proliferation in vitro but does not reduce the neointimal response to balloon catheter injury. Atherosclerosis 1995, 118:57-66.
27. Chesik D., De Keyser J., Bron R., Fuhler G.M. Insulin-like growth factor binding protein-1 activates integrin-mediated intracellular signaling and migration in oligodendrocytes. J Neurochem 2010, 113:1319-1330.
28. Novosyadlyy R., Lelbach A., Sheikh N., et al. Temporal and spatial expression of IGF-I and IGFBP-1 during acute-phase response induced by localized inflammation in rats. Growth Horm IGF Res 2009, 19:51-60.
29. Lelbach A., Scharf J.G., Ramadori G. Regulation of insulin-like growth factor-I and of insulin-like growth factor binding protein-1, -3 and -4 in cocultures of rat hepatocytes and kupffer cells by interleukin-6. J Hepatol 2001, 35:558-567.
30. Yeap B.B., Chubb S.A., McCaul K.A., et al. Associations of IGF1 and IGFBPS 1 and 3 with all-cause and cardiovascular mortality in older men: The health in men study. Eur J Endocrinol 2011, 164:715-723.